Second Opinion Referrals of Cancer Patients in Japan—A Nationwide Study
Cancer Science · 2025
DOI: 10.1111/cas.70012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Mieko Takasawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health Services Research, National Cancer Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Referral and Consultation, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center Japan.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Seeking a second opinion (SO) is a patient's right that is essential to appropriate decision‐making for their care and treatment. In Japan, however, no previous studies have provided objective data on the nationwide practice of SO among cancer patients. In this study, we investigated SO referrals, including delays in initiating care, using data from nationwide hospital‐based cancer registries and 2018–2020 the Diagnosis Procedure Combination (DPC) survey. Among the more than 2.6 million patients diagnosed with cancer, 1.6% received SO referral letters as reimbursement. The referral rates varied based on sex, age, and geographic regions. A total of 52.1% of SO were sought before active treatment of the tumor. Approximately 60% of the patients who sought SO prior to the initial treatment returned to their original provider for treatment. The average period from diagnosis to the start of treatment among those who sought SO was 18 days and 22 days longer for non‐small lung cancer and breast cancer, respectively, than among those who did not seek SO. In the future, the risk–benefit of SO referral should be examined, considering both the prognostic impact of treatment delay due to SO and the psychological benefits for the patient gained from SO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Health Services Research, National Cancer Center, Tokyo, Japan.
- Department of Public Health and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Cancer Prevention and Epidemiology, Center for Cancer Research, NHO Shikoku Cancer Center, Matsuyama, Ehime, Japan.
ORCID-Profile: Mieko Takasawa, Norihiro Teramoto
Förderung
- National Cancer Center Japan
Zitieren
APA
Takasawa, M., Teramoto, N., Yamashita, N., & Higashi, T. (2025). Second Opinion Referrals of Cancer Patients in Japan—A Nationwide Study. Cancer Science. https://doi.org/10.1111/cas.70012
Vancouver
Takasawa M, Teramoto N, Yamashita N, Higashi T. Second Opinion Referrals of Cancer Patients in Japan—A Nationwide Study. Cancer Science. 2025. doi:10.1111/cas.70012
BibTeX
@article{Takasawa2025,
author = {Takasawa, Mieko and Teramoto, Norihiro and Yamashita, Natsumi and Higashi, Takahiro},
title = {Second Opinion Referrals of Cancer Patients in Japan—A Nationwide Study},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70012}
}
EUVIMED